Rongguang Shao Selected Research

Neoplasms (Cancer)

2/2024	Myofibrillogenesis Regulator-1 Regulates the Ubiquitin Lysosomal Pathway of Notch3 Intracellular Domain Through E3 Ubiquitin-Protein Ligase Itchy Homolog in the Metastasis of Non-Small Cell Lung Cancer.
11/2023	Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication.
1/2023	The functions and regulatory pathways of S100A8/A9 and its receptors in cancers.
1/2023	Biomimetic Nanobomb for Synergistic Therapy with Inhibition of Cancer Stem Cells.
5/2022	YOD1 serves as a potential prognostic biomarker for pancreatic cancer.
3/2022	ER-phagy in the Occurrence and Development of Cancer.
3/2022	Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
1/2022	An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms.
1/2020	Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy.
1/2020	A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongguang Shao Research Topics

Disease

22	Neoplasms (Cancer) 02/2024 - 01/2009
7	Breast Neoplasms (Breast Cancer) 03/2022 - 10/2003
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2019
4	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2018
2	Inflammation (Inflammations) 04/2024 - 01/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2015
2	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2023
2	Cardiotoxicity 05/2018 - 11/2015
2	Hepatocellular Carcinoma (Hepatoma) 11/2014 - 04/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2022
1	Asthma (Bronchial Asthma) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Glioma (Gliomas) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Paroxysmal nonkinesigenic dyskinesia 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 01/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016
1	Carcinoma (Carcinomatosis) 04/2014
1	Retinoblastoma (Glioblastoma, Retinal) 02/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2006
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2020
3	Antineoplastic Agents (Antineoplastics)IBA 05/2018 - 11/2014
2	Gemcitabine FDA Link 11/2023 - 01/2022
2	TOR Serine-Threonine KinasesIBA 01/2023 - 06/2015
2	CateninsIBA 01/2023 - 03/2022
2	3- O- (4- O- galactopyranosyl- glucopyranosyl)- 1,2- di- O- tetradecyl- sn- glyceryolIBA 01/2022 - 01/2019
2	LigandsIBA 01/2020 - 01/2019
2	C 1027IBA 01/2019 - 02/2006
2	Peptides (Polypeptides)IBA 01/2019 - 04/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2016 - 11/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 11/2015
2	MatrinesIBA 01/2016 - 11/2014
2	sophoridinolIBA 01/2016 - 11/2014
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2009 - 02/2006
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2024
1	UbiquitinIBA 02/2024
1	PlatinumIBA 11/2023
1	Liposomes (Liposome)IBA 11/2023
1	Mitochondrial DNA (mtDNA)IBA 11/2023
1	miriplatinIBA 11/2023
1	Toll-Like Receptor 4IBA 01/2023
1	Mitogen-Activated Protein KinasesIBA 01/2023
1	ChemokinesIBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	Protein Kinase CIBA 01/2023
1	CytokinesIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 05/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Cell Adhesion MoleculesIBA 05/2022
1	Deubiquitinating EnzymesIBA 05/2022
1	Transcription Factor CHOPIBA 03/2022
1	CaspasesIBA 03/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Ethanolamine (Colamine)IBA 01/2020
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 01/2020
1	ClathrinIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Zinc Finger Protein GLI1IBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	ResveratrolIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Cytotoxins (Cytolysins)IBA 01/2019
1	ras ProteinsIBA 01/2019
1	Topoisomerase InhibitorsIBA 05/2018
1	IMB5043IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	QuinolizidinesIBA 01/2016
1	DNA TopoisomerasesIBA 11/2015
1	Ouabain (G Strophanthin)IBA 06/2015
1	Cardiac GlycosidesIBA 06/2015
1	Digoxin (Digitek)FDA LinkGeneric 06/2015
1	Mitogen-Activated Protein Kinase 3IBA 06/2015
1	Adenosine Triphosphatases (ATPase)IBA 06/2015
1	EstersIBA 11/2014
1	sophoridinic acidIBA 11/2014
1	MutagensIBA 04/2014
1	Cisplatin (Platino)FDA LinkGeneric 04/2014
1	U 0126 (UO 126)IBA 04/2013
1	sphingosine kinaseIBA 04/2013
1	Cyclin B1IBA 02/2006
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 02/2006
1	Estrogens (Estrogen)FDA Link 10/2003
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2003
1	Estrogen ReceptorsIBA 10/2003

Therapy/Procedure

8	Therapeutics 01/2023 - 04/2013
1	Radiotherapy 03/2022
1	Drug Therapy (Chemotherapy) 03/2022